• Search
  • Helpdesk
  • Sales contact

Decentralized Clinical Trials
Essential tips to avoid common pitfalls

Last updated: November 22, 2024

Despite the numerous advantages of Decentralized Clinical Trials, reducing on-site visit means that data endpoints need to be captured via other means.
Data must not be lost when patients do not come to site for several weeks, data quality must be guaranteed throughout the project, and data must be protected even when patients use their own mobile.
How can the common pitfalls that come with DCTs be avoided?

CONTENT

#1 Avoiding data loss when patients visit frequency is reduced

#2 Tackling technology adoption risks

#3 Securing data quality when collecting data from multiple sources

#4 Ensuring data protection

Read the full white paper 👇

Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

The critical importance of Patient Reported Outcomes (PROs) for Emerging Biopharma Companies – Webinar

July 9 • 11-12AM EDT / 4-5PM GMT / 5-6PM CET
In today’s competitive landscape, biotech and emerging biopharma companies (EBPs) must demonstrate the value of their innovations early and convincingly....

DPHARM 2025

SEPT 16-17 2025 • Philadelphia, PA, USA
Booth #44 16th Annual Outsourcing in Clinical Trials East Coast 2025 - Arena International

SCDM 2025

Baltimore, Maryland, USA - 27-30 SEPT 2025
Annual Conference 2025 – SCDMLive    

SCOPE Europe 2025

OCT 14-15 2025 • Barcelona, Spain
SCOPE Europe | Summit for Clinical Operations Executives | October 14-15, 2025 |Barcelona, Spain